Fidelity Investments’s Hepion Pharmaceuticals HEPA Stock Holding History

Fidelity Investments’s Portfolio HEPA Stock Details HEPA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-100	Closed	-$43	–	5400
2025 Q1	$43	Buy	+100	New	+$974	﹤0.01%	5177

Other funds holding HEPA

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Fidelity Investments's HEPA Position: Q2 2025 in Review

Fidelity Investments sold out of Hepion Pharmaceuticals (HEPA) in Q2 2025, closing a stake of 100 shares — an estimated $43 sold.

Fidelity Investments first reported a position in HEPA in Q1 2025 and held it in 1 quarter. The position peaked at $43 in Q1 2025. 4 funds tracked by Wall St. Rank hold HEPA as of Q2 2025.

Fidelity Investments reported no remaining Hepion Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Fidelity Investments sold 100 Hepion Pharmaceuticals shares in Q2 2025, an estimated $43.
Fidelity Investments first reported a position in Hepion Pharmaceuticals in Q1 2025 and held it in 1 quarter.
Fidelity Investments's Hepion Pharmaceuticals position peaked at $43 in Q1 2025.
4 funds tracked by Wall St. Rank held Hepion Pharmaceuticals as of Q2 2025.

Based on Fidelity Investments's 13F filing for Q2 2025, filed 14 Aug 2025.